scholarly journals Amrubicin is effective against small cell carcinoma of the prostate as a second-line chemotherapeutic agent: A case report

2019 ◽  
Vol 2 (3) ◽  
pp. 133-136
Author(s):  
Fumisato Maesaka ◽  
Yasushi Nakai ◽  
Mitsuru Tomizawa ◽  
Takuya Owari ◽  
Makito Miyake ◽  
...  
2017 ◽  
Vol 22 (3) ◽  
pp. 160-163
Author(s):  
Munire Durmaz ◽  
Fahriye Kilinc ◽  
Ibrahim Buldu ◽  
Halil Kiyici ◽  
Bilal Arik

2011 ◽  
Vol 4 (1) ◽  
pp. 88-95 ◽  
Author(s):  
Antonio Capizzello ◽  
Evangelia Peponi ◽  
Nafsika Simou ◽  
Dimitrios Ntaskagiannis ◽  
Ifigenia Tasiou ◽  
...  

2020 ◽  
Vol 1 (4) ◽  
pp. 23-29
Author(s):  
Sezgin Okçelik ◽  
Elmas Özgün ◽  
Şakir Eser ◽  
Mehmet Polat ◽  
Muhammed Cihan Temel ◽  
...  

Small cell carcinoma of the prostate is a rare and highly aggressive subtype of prostate cancers. In this case report, we evaluated a patient applied our outpatient clinic with acute urinary retention, whose pathology reported as pure small cell carcinoma of the prostate. A 73-year-old male patient was admitted to our outpatient clinic with acute urinary retention. Digital rectal examination was normal. The PSA value was 1.81 ng/dl. Prostate size was 101 cc. Open prostatectomy was performed. The pathology of the patient was reported as pure small cell prostate carcinoma. Four cycles of etoposide and cisplatin chemotherapy were administered to the patient. The patient died 13 months later after the first diagnosis. We evaluated the pathological and clinical findings of small cell carcinoma of the prostate.


1997 ◽  
Vol 4 (3) ◽  
pp. 321-323 ◽  
Author(s):  
Katsuyuki Sano ◽  
Keikoku Miyai ◽  
Sachiko Yoshida

2007 ◽  
Vol 39 (1) ◽  
pp. 157-160 ◽  
Author(s):  
Mustafa Kaplan ◽  
Irfan H. Atakan ◽  
Selcuk Bilgi ◽  
Osman Inci

Sign in / Sign up

Export Citation Format

Share Document